» Articles » PMID: 8803595

Expression of Adhesion Molecules and Extracellular Matrix Proteins in Glioblastomas: Relation to Angiogenesis and Spread

Overview
Journal Histopathology
Date 1996 Jun 1
PMID 8803595
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the immunohistochemical expression of inducible adhesion molecules, integrins and extracellular matrix proteins in 10 cases of glioblastoma multiforme in order to investigate their angiogenesis, local invasiveness, poor metastasizing properties and their lack of tumour infiltrating leukocytes. In glioblastomas endothelial proliferations represent the majority of vascular structures; they were positive for endothelial markers (vWF, CD31, VE-cadherin) and negative for macrophage markers (CD68, PAM-1). Immunohistologically, they were subtyped into: 1 solid-glomeruloid ICAM-1, alpha 2 beta 1, alpha 3 beta 1, alpha 5 beta 1 negative; 2 channelled-branching ICAM-1 negative and alpha 2 beta 1, alpha 3 beta 1, alpha 5 beta 1 positive; 3 channelled-telangiectatic ICAM-1, alpha 2 beta 1, alpha 3 beta 1, alpha 5 beta 1 positive. In channelled proliferations, the expression and distribution of tenascin and merosin in the basal membrane was similar to that of normal brain vessels. The expression of all these molecules might indicate different steps of maturation of endothelial proliferations. The majority of endothelial proliferations may be immunohistologically considered as incomplete vascular structures; this might account for the low metastasizing tendency and low recruitment of leukocytes by these tumours. Neoplastic astrocytes were GFAP-1, ICAM-1, VCAM-1, alpha 2 beta 1, alpha 3 beta 1 and alpha 5 beta 1 immunoreactive and alpha 6 beta 4 negative: this allows them to interact with extracellular matrix proteins and might, in part, explain the tendency of glioblastomas to infiltrate locally.

Citing Articles

Importance of GFAP isoform-specific analyses in astrocytoma.

van Bodegraven E, van Asperen J, Robe P, Hol E Glia. 2019; 67(8):1417-1433.

PMID: 30667110 PMC: 6617972. DOI: 10.1002/glia.23594.


Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma.

Angara K, Borin T, Arbab A Transl Oncol. 2017; 10(4):650-660.

PMID: 28668763 PMC: 5496207. DOI: 10.1016/j.tranon.2017.04.007.


Assessment of vascularity in glioblastoma and its implications on patient outcomes.

McGahan B, Neilsen B, Kelly D, McComb R, Kazmi S, White M J Neurooncol. 2017; 132(1):35-44.

PMID: 28102487 PMC: 5479489. DOI: 10.1007/s11060-016-2350-3.


Role of Matricellular Proteins in Disorders of the Central Nervous System.

Jayakumar A, Apeksha A, Norenberg M Neurochem Res. 2016; 42(3):858-875.

PMID: 27878658 DOI: 10.1007/s11064-016-2088-5.


Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance.

Fidoamore A, Cristiano L, Antonosante A, dAngelo M, Di Giacomo E, Astarita C Stem Cells Int. 2016; 2016:6809105.

PMID: 26880981 PMC: 4736577. DOI: 10.1155/2016/6809105.